Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU

Chest
R P Ryskamp, S J Trottier

Abstract

To assess the utilization of venous thromboembolism (VTE) prophylaxis in a medical-surgical ICU. Prospective cohort study. A closed (mandatory critical care consult) medical-surgical ICU of a large community teaching hospital. The medical records of consecutive medical-surgical ICU admissions were evaluated by a single investigator during a 3-month period. Risk factors for VTE and the type and timing of VTE prophylaxis were recorded. Of 308 admissions evaluated, 209 were included in the study. VTE prophylaxis was administered within the first 24 h of ICU admission to 179 of the 209 study patients or 86%. Fifty-three percent (n=111) were surgical patients and 47% (n=98) were medical patients. The study patients had an average of 4.4 risk factors for VTE. Thirty study patients (14%) did not receive VTE prophylaxis. Eighty-six percent of the medical-surgical patients included in this study received VTE prophylaxis. The utilization of VTE prophylaxis described in this study is higher compared to previously published data. The nature of physician coverage in our medical-surgical ICU (closed unit), consistent practice patterns of a designated ICU staff, and a continuing medical education program involving VTE prophylaxis are the fact...Continue Reading

References

Jul 26, 1995·JAMA : the Journal of the American Medical Association·D R HirschS Z Goldhaber

❮ Previous
Next ❯

Citations

Dec 24, 2003·Journal of Critical Care·Jean Claude LacheradeUNKNOWN French and Canadian ICU Directors Groups
Dec 31, 1998·The American Journal of Medicine·S Saint, M A Matthay
Apr 9, 2004·Critical Care Medicine·Maureen O MeadeUNKNOWN Canadian Critical Care Trials Group
Jan 30, 2010·Critical Care Medicine·Deborah J Cook, Mark A Crowther
Apr 3, 2004·Thrombosis Journal·Antonio VallanoJaume Pérez-Bartolí
Dec 12, 2003·Chest·William Geerts, Rita Selby
Aug 5, 2010·Current Problems in Surgery·Matthew J MartinNiten Singh
Nov 1, 2011·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Nancy S LloydR Brian Haynes
Dec 28, 2005·The American Journal of Medicine·Krista L LentineMichael K Gould
Nov 29, 2005·Journal of Critical Care·Michael K Gould
Nov 29, 2005·Journal of Critical Care·Deborah CookUNKNOWN VTE in the ICU Workshop Participants
Jul 1, 1999·Clinics in Chest Medicine·B M LegereA C Arroliga
Jul 5, 2005·Critical Care Clinics·Theodore E Warkentin, Deborah J Cook
Apr 11, 2003·Clinics in Chest Medicine·Ana T Rocha, Victor F Tapson
Nov 11, 2006·Journal of Intensive Care Medicine·Hassan KhouliPeter Homel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.